Standout Papers
Immediate Impact
32 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
2024 Standout
Works of Ali Adili being referenced
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
2022 Standout
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ali Adili | 191 | 94 | 237 | 151 | 28 | 512 | |
| Yan Qu | 240 | 113 | 153 | 119 | 33 | 492 | |
| Neşe Ünver | 177 | 75 | 231 | 239 | 18 | 542 | |
| Fengjuan Lin | 270 | 161 | 164 | 104 | 30 | 557 | |
| Xia Li | 200 | 130 | 212 | 136 | 35 | 571 | |
| Ryo Sato | 272 | 103 | 281 | 63 | 22 | 542 | |
| Aitor Benedicto | 200 | 85 | 180 | 113 | 26 | 558 | |
| Praveen Neeli | 276 | 72 | 116 | 123 | 23 | 487 | |
| Matteo Gallazzi | 174 | 105 | 171 | 266 | 28 | 576 | |
| Antao Xu | 219 | 67 | 240 | 205 | 20 | 624 | |
| Lijuan Huang | 216 | 84 | 164 | 184 | 26 | 605 |
All Works
Loading papers...